Long-Term Effectiveness of XEN 45 Gel-Stent in Open-Angle Glaucoma Patients.
Maria Teresa Marcos-ParraJavier Alejandro Salinas-LópezCarlos Mateos-MarcosLucia Moreno-CastroAngi Lizbeth Mendoza-MoreiraJuan José Pérez-SantonjaPublished in: Clinical ophthalmology (Auckland, N.Z.) (2023)
XEN implant significantly lowered IOP and reduced the need of ocular hypotensive medication, while maintaining a good safety profile. Beyond week-1, there were no significant differences in IOP lowering between XEN-solo and XEN+Phacoemulsification groups.